多重耐药性的临床相关性。 - Suppr

Suppr

超能文献

The clinical relevance of multidrug resistance.

作者信息

Bellamy W T, Dalton W S, Dorr R T

机构信息

Arizona Cancer Center, University of Arizona, Tucson 85724.

出版信息

Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.

DOI:10.3109/07357909009012080

PMID:1979932

Abstract

摘要

相似文献

The clinical relevance of multidrug resistance.

Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.

Mechanism of multidrug resistance.

Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.

Multidrug resistance: clinical findings and implications.

Cancer Treat Res. 1989;42:63-77. doi: 10.1007/978-1-4613-1747-0_4.

Multidrug resistance in human cancer.

Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.

Multidrug resistance: molecular biology and clinical relevance.

J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.

Laboratory aspects of multidrug resistance.

Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3.

Multidrug resistance in cancer.

BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148.

Cellular resistance to drugs.

Cancer Invest. 1989;7(2):211-2. doi: 10.3109/07357908909038287.

Drug resistance and cancer.

Adv Exp Med Biol. 1993;330:287-305. doi: 10.1007/978-1-4615-2926-2_20.

P glycoprotein (P-gp) and drug resistance--time for reappraisal?

Br J Cancer. 1993 Apr;67(4):641-3. doi: 10.1038/bjc.1993.119.

引用本文的文献

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Br J Pharmacol. 1996 Nov;119(5):1038-44. doi: 10.1111/j.1476-5381.1996.tb15775.x.

Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.

Eur J Nucl Med. 1996 Aug;23(8):980-6. doi: 10.1007/BF01084375.

Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.

Med Oncol. 1995 Mar;12(1):9-14. doi: 10.1007/BF01571403.

Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.

Cancer Chemother Pharmacol. 1994;34(2):96-102. doi: 10.1007/BF00685925.

Cellular models for multiple drug resistance in cancer.

In Vitro Cell Dev Biol. 1993 Mar;29A(3 Pt 1):171-9. doi: 10.1007/BF02634176.

SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.

Br J Cancer. 1992 Jan;65(1):11-8. doi: 10.1038/bjc.1992.3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

The clinical relevance of multidrug resistance.

Cancer Invest. 1990;8(5):547-62. doi: 10.3109/07357909009012080.

Mechanism of multidrug resistance.

Biochim Biophys Acta. 1988 Aug 3;948(1):87-128. doi: 10.1016/0304-419x(88)90006-6.

Multidrug resistance: clinical findings and implications.

Cancer Treat Res. 1989;42:63-77. doi: 10.1007/978-1-4613-1747-0_4.

Multidrug resistance in human cancer.

Crit Rev Oncol Hematol. 1992;12(3):243-53. doi: 10.1016/1040-8428(92)90057-w.

Multidrug resistance: molecular biology and clinical relevance.

J Natl Cancer Inst. 1989 Jun 21;81(12):907-10. doi: 10.1093/jnci/81.12.907.

Laboratory aspects of multidrug resistance.

Cancer Treat Res. 1989;42:45-59. doi: 10.1007/978-1-4613-1747-0_3.

Multidrug resistance in cancer.

BMJ. 1994 Jan 15;308(6922):148-9. doi: 10.1136/bmj.308.6922.148.

Cellular resistance to drugs.

Cancer Invest. 1989;7(2):211-2. doi: 10.3109/07357908909038287.

Drug resistance and cancer.

Adv Exp Med Biol. 1993;330:287-305. doi: 10.1007/978-1-4615-2926-2_20.

P glycoprotein (P-gp) and drug resistance--time for reappraisal?

Br J Cancer. 1993 Apr;67(4):641-3. doi: 10.1038/bjc.1993.119.

引用本文的文献

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein.

Br J Pharmacol. 1996 Nov;119(5):1038-44. doi: 10.1111/j.1476-5381.1996.tb15775.x.

Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression.

Eur J Nucl Med. 1996 Aug;23(8):980-6. doi: 10.1007/BF01084375.

Interaction of alpha-interferon with chemotherapeutic agents: effects on cytotoxic drug metabolism and multiple drug resistance.

Med Oncol. 1995 Mar;12(1):9-14. doi: 10.1007/BF01571403.

Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.

Cancer Chemother Pharmacol. 1994;34(2):96-102. doi: 10.1007/BF00685925.

Cellular models for multiple drug resistance in cancer.

In Vitro Cell Dev Biol. 1993 Mar;29A(3 Pt 1):171-9. doi: 10.1007/BF02634176.

SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.

Br J Cancer. 1992 Jan;65(1):11-8. doi: 10.1038/bjc.1992.3.